Skip to main content

Table 2 Frequency of acute and late Genitourinary (GU) and Gastrointestinal (GI) toxicity

From: Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer

  

# Resolved

Acute GU:

  

 Grade 0

7 (15 %)

-

 Grade 1

23 (48 %)

16

 Grade 2

18 (37 %)

17 (1 dose de-escalation)

Acute GI:

  

 Grade 0

23 (48 %)

 

 Grade 1

20 (42 %)

10

 Grade 2

5 (10 %)

1

Late GU:

  

 Grade 0

25 (52 %)

-

 Grade 1

10 (21 %)

3

 Grade 2

12 (25 %)

9

 Grade 3

1 (2 %)

1 (Obstruction)

Late GI:

  

 Grade 0

42 (87.5 %)

-

 Grade 1

6 (12.5 %)

1

  1. Acute Toxicity: Maximum grade observed during the first 6 months from start of protocol therapy
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us